FDA to consider authorizing Pfizer's COVID vaccine for kids under 5
Pfizer and its partner BioNTech have asked the Food and Drug Administration to allow their COVID vaccine to be used in children 4 years to 6 months old.
Stay updated with breaking news from Mark Mcclellan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer and its partner BioNTech have asked the Food and Drug Administration to allow their COVID vaccine to be used in children 4 years to 6 months old.
Pfizer and its partner BioNTech have asked the Food and Drug Administration to allow their COVID vaccine to be used in children 4 years to 6 months old.
Pfizer and its partner BioNTech have asked the Food and Drug Administration to allow their COVID vaccine to be used in children 4 years to 6 months old.
Pfizer and its partner BioNTech have asked the Food and Drug Administration to allow their COVID vaccine to be used in children 4 years to 6 months old.
U.S. regulators are planning to review and authorize Pfizer and BioNTech's COVID-19 vaccine for children younger than 5 before data on a third -- and potentially necessary -- shot is available.